These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
46. Antiphospholipid syndrome in childhood systemic lupus erythematosus. Paudyal B J Nepal Health Res Counc; 2010 Apr; 8(1):51-4. PubMed ID: 21879016 [TBL] [Abstract][Full Text] [Related]
47. [Antiphospholipid sydrome--recurrent thrombosis and foetal loss due to antiphospholipid antibodies]. Elezović I; Matijević-Aleksić N; Rolović Z Srp Arh Celok Lek; 1994; 122(5-6):179-81. PubMed ID: 17977423 [TBL] [Abstract][Full Text] [Related]
48. Relapsing splenic vein thrombosis associated with antiphospholipid antibodies in a patient with wegener granulomatosis. Steen KS; Peters MJ; Zweegman S; de Groot PG; Voskuyl AE J Clin Rheumatol; 2007 Apr; 13(2):92-3. PubMed ID: 17414539 [TBL] [Abstract][Full Text] [Related]
49. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A; de Azevedo MN; de Souza Papi JA; Petri M J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [TBL] [Abstract][Full Text] [Related]
51. [Pulmonary thromboembolism and deep venous thrombosis in the antiphospholipid syndrome--case report]. Vucićević-Trobok J; Bogdanov B; Trifković M Med Pregl; 2003; 56(1-2):85-8. PubMed ID: 12793194 [TBL] [Abstract][Full Text] [Related]
52. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Avcin T; Cimaz R; Silverman ED; Cervera R; Gattorno M; Garay S; Berkun Y; Sztajnbok FR; Silva CA; Campos LM; Saad-Magalhaes C; Rigante D; Ravelli A; Martini A; Rozman B; Meroni PL Pediatrics; 2008 Nov; 122(5):e1100-7. PubMed ID: 18955411 [TBL] [Abstract][Full Text] [Related]
53. [Antiphospholipid syndrome]. Yuste JR; Beloqui O; De la Peña A; Prieto J Rev Med Univ Navarra; 1998; 42(4):194-207. PubMed ID: 10420931 [TBL] [Abstract][Full Text] [Related]
54. Pyoderma gangrenosum and extensive caval thrombosis associated with the antiphospholipid syndrome--a case report. Chacek S; MacGregor-Gooch J; Halabe-Cherem J; Nellen-Hummel H; Quiñones-Galvan A Angiology; 1998 Feb; 49(2):157-60. PubMed ID: 9482516 [TBL] [Abstract][Full Text] [Related]
55. [Antiphospholipid antibodies and neurological disorders. Types and mechanisms]. Viñets C; Montiel I; González MJ; Antem M Rev Neurol; 1996 Oct; 24(134):1224-8. PubMed ID: 8983718 [TBL] [Abstract][Full Text] [Related]
56. Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Pierangeli SS; Chen PP; González EB Curr Opin Hematol; 2006 Sep; 13(5):366-75. PubMed ID: 16888443 [TBL] [Abstract][Full Text] [Related]
57. Intracardiac thrombosis and acute myocardial infarction as initial presentation of antiphospholipid syndrome. Sharma AK; Baig MW; Heist EK Am J Med Sci; 2011 Sep; 342(3):254-6. PubMed ID: 21829132 [TBL] [Abstract][Full Text] [Related]